Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marnix L. M. Lybeert"'
Autor:
Jan J. Jobsen, Lambert Naudin ten Cate, Marnix L. M. Lybeert, Astrid Scholten, Elzbieta M. van der Steen-Banasik, Job van der Palen, Marika C. Stenfert Kroese, Annerie Slot, Eltjo M. J. Schutter, Sabine Siesling
Publikováno v:
Obstetrics and Gynecology International, Vol 2011 (2011)
Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma. Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvem
Externí odkaz:
https://doaj.org/article/2c877f47e5d943dcaff0a2e37509735d
Autor:
Christophe, Fermé, José, Thomas, Pauline, Brice, Olivier, Casasnovas, Andrej, Vranovsky, Serge, Bologna, Pieternella J, Lugtenburg, Réda, Bouabdallah, Patrice, Carde, Catherine, Sebban, Houchingue, Eghbali, Gilles, Salles, Gustaaf W, van Imhoff, Antoine, Thyss, Evert M, Noordijk, Oumédaly, Reman, Marnix L M, Lybeert, Maud, Janvier, Michele, Spina, Bruno, Audhuy, John M M, Raemaekers, Richard, Delarue, Bruno, Anglaret, Okke, de Weerdt, Zora, Marjanovic, Robbert J H A, Tersteeg, Daphne, de Jong, Josette, Brière, Michel, Henry-Amar
Publikováno v:
European journal of cancer (Oxford, England : 1990). 81
For early-stage Hodgkin lymphoma (HL), optimal chemotherapy regimen and the number of cycles to be delivered remain to settle down. The H9-U trial compared three modalities of chemotherapy followed by involved-field radiotherapy (IFRT) in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0f1d0049d68962e0b230d88903c6e87b
https://pubmed.ncbi.nlm.nih.gov/28601705
https://pubmed.ncbi.nlm.nih.gov/28601705
Autor:
Marieke W. J. Louwman, Maryska L.G. Janssen-Heijnen, Valery E.P.P. Lemmens, Marnix L. M. Lybeert, Jan Willem Coebergh, Philip H. P. Poortmans M.D., Ans J. C. M. Vulto
Publikováno v:
Cancer, 106(12), 2734-2742. John Wiley & Sons Inc.
BACKGROUND The objective of this study was to study the influence of age and comorbidity on receiving radiotherapy (RT) in primary treatment of cancer. METHODS In a population-based setting, the authors calculated the proportion of irradiated patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b75202aa5b683f7757d8e8e531d04ab5
https://doi.org/10.1002/cncr.21934
https://doi.org/10.1002/cncr.21934
Autor:
Ans J. C. M. Vulto, Valery E. P. P. Lemmens, Marieke W. J. Louwman, Maryska L. G. Janssen‐Heijnen, Philip H. P. Poortmans, Marnix L. M. Lybeert, Jan Willem W. Coebergh
Publikováno v:
Cancer (0008543X); Jun2006, Vol. 106 Issue 12, p2734-2742, 9p
Autor:
Jean-Paul de Zoete, Grard A. P. Nieuwenhuijzen, Iris A C de Vries, Marnix L M Lybeert, Thomas B J Demeyere, Marjolein M S van Acht
Publikováno v:
Radiation Oncology, Vol 5, Iss 1, p 7 (2010)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background Castleman disease (CD) is a rare benign disorder characterised by hyperplasia of lymphoid tissue that may develop at a single site or throughout the body. The etiology of this disorder is unclear, although the histopathological presentatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7bec5c316da0b56f9a4e4691b89b433